Clinical Trials Directory

Trials / Completed

CompletedNCT05702190

Opium Tincture Against Chronic Diarrhea - Healthy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Asbjørn Mohr Drewes · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the mechanistic anti-propulsive effects of opium tincture on the gastrointestinal tract of a cohort of healthy participants.

Detailed description

Opium tincture is used a symptomatic drug against chronic diarrhea even though no clinical studies have investigated the effect on gastrointestinal function. With this randomized, double-blind, placebo-controlled cross-over trial in 20 healthy participants, the investigators wish to provide evidence-based insights into the effects of opium tincture on gastrointestinal function. Additionally, effects on the central nervous system will be investigated a tertiary aim.

Conditions

Interventions

TypeNameDescription
DRUGOpium tinctureSelf-administration of opium tincture (10 mg/ml) as 2x5 drops on day 1, 3x10 drops on days 2-8, and 1x10 drops on day 9 in each study period.
DRUGPlaceboSelf-administration of placebo as 2x5 drops on day 1, 3x10 drops on days 2-8, and 1x10 drops on day 9 in each study period.

Timeline

Start date
2021-03-09
Primary completion
2022-06-01
Completion
2022-06-01
First posted
2023-01-27
Last updated
2023-01-30

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05702190. Inclusion in this directory is not an endorsement.